Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity.
Despite mounting evidence that epigenetic abnormalities play a key role in cancer biology, their contributions to the malignant phenotype remain poorly understood. Here we studied genome-wide DNA methylation in normal B-cell populations and subtypes of B-cell non-Hodgkin lymphoma: follicular lymphom...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS Genetics |
| Online Access: | https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1003137&type=printable |
| _version_ | 1826799356132458496 |
|---|---|
| author | Subhajyoti De Rita Shaknovich Markus Riester Olivier Elemento Huimin Geng Matthias Kormaksson Yanwen Jiang Bruce Woolcock Nathalie Johnson Jose M Polo Leandro Cerchietti Randy D Gascoyne Ari Melnick Franziska Michor |
| author_facet | Subhajyoti De Rita Shaknovich Markus Riester Olivier Elemento Huimin Geng Matthias Kormaksson Yanwen Jiang Bruce Woolcock Nathalie Johnson Jose M Polo Leandro Cerchietti Randy D Gascoyne Ari Melnick Franziska Michor |
| author_sort | Subhajyoti De |
| collection | DOAJ |
| description | Despite mounting evidence that epigenetic abnormalities play a key role in cancer biology, their contributions to the malignant phenotype remain poorly understood. Here we studied genome-wide DNA methylation in normal B-cell populations and subtypes of B-cell non-Hodgkin lymphoma: follicular lymphoma and diffuse large B-cell lymphomas. These lymphomas display striking and progressive intra-tumor heterogeneity and also inter-patient heterogeneity in their cytosine methylation patterns. Epigenetic heterogeneity is initiated in normal germinal center B-cells, increases markedly with disease aggressiveness, and is associated with unfavorable clinical outcome. Moreover, patterns of abnormal methylation vary depending upon chromosomal regions, gene density and the status of neighboring genes. DNA methylation abnormalities arise via two distinct processes: i) lymphomagenic transcriptional regulators perturb promoter DNA methylation in a target gene-specific manner, and ii) aberrant epigenetic states tend to spread to neighboring promoters in the absence of CTCF insulator binding sites. |
| first_indexed | 2024-12-22T08:31:03Z |
| format | Article |
| id | doaj.art-9416ee16f6cc4ee4818b2492ae638bc6 |
| institution | Directory Open Access Journal |
| issn | 1553-7390 1553-7404 |
| language | English |
| last_indexed | 2025-03-17T00:33:47Z |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Genetics |
| spelling | doaj.art-9416ee16f6cc4ee4818b2492ae638bc62025-02-21T05:34:06ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042013-01-0191e100313710.1371/journal.pgen.1003137Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity.Subhajyoti DeRita ShaknovichMarkus RiesterOlivier ElementoHuimin GengMatthias KormakssonYanwen JiangBruce WoolcockNathalie JohnsonJose M PoloLeandro CerchiettiRandy D GascoyneAri MelnickFranziska MichorDespite mounting evidence that epigenetic abnormalities play a key role in cancer biology, their contributions to the malignant phenotype remain poorly understood. Here we studied genome-wide DNA methylation in normal B-cell populations and subtypes of B-cell non-Hodgkin lymphoma: follicular lymphoma and diffuse large B-cell lymphomas. These lymphomas display striking and progressive intra-tumor heterogeneity and also inter-patient heterogeneity in their cytosine methylation patterns. Epigenetic heterogeneity is initiated in normal germinal center B-cells, increases markedly with disease aggressiveness, and is associated with unfavorable clinical outcome. Moreover, patterns of abnormal methylation vary depending upon chromosomal regions, gene density and the status of neighboring genes. DNA methylation abnormalities arise via two distinct processes: i) lymphomagenic transcriptional regulators perturb promoter DNA methylation in a target gene-specific manner, and ii) aberrant epigenetic states tend to spread to neighboring promoters in the absence of CTCF insulator binding sites.https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1003137&type=printable |
| spellingShingle | Subhajyoti De Rita Shaknovich Markus Riester Olivier Elemento Huimin Geng Matthias Kormaksson Yanwen Jiang Bruce Woolcock Nathalie Johnson Jose M Polo Leandro Cerchietti Randy D Gascoyne Ari Melnick Franziska Michor Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity. PLoS Genetics |
| title | Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity. |
| title_full | Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity. |
| title_fullStr | Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity. |
| title_full_unstemmed | Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity. |
| title_short | Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity. |
| title_sort | aberration in dna methylation in b cell lymphomas has a complex origin and increases with disease severity |
| url | https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1003137&type=printable |
| work_keys_str_mv | AT subhajyotide aberrationindnamethylationinbcelllymphomashasacomplexoriginandincreaseswithdiseaseseverity AT ritashaknovich aberrationindnamethylationinbcelllymphomashasacomplexoriginandincreaseswithdiseaseseverity AT markusriester aberrationindnamethylationinbcelllymphomashasacomplexoriginandincreaseswithdiseaseseverity AT olivierelemento aberrationindnamethylationinbcelllymphomashasacomplexoriginandincreaseswithdiseaseseverity AT huimingeng aberrationindnamethylationinbcelllymphomashasacomplexoriginandincreaseswithdiseaseseverity AT matthiaskormaksson aberrationindnamethylationinbcelllymphomashasacomplexoriginandincreaseswithdiseaseseverity AT yanwenjiang aberrationindnamethylationinbcelllymphomashasacomplexoriginandincreaseswithdiseaseseverity AT brucewoolcock aberrationindnamethylationinbcelllymphomashasacomplexoriginandincreaseswithdiseaseseverity AT nathaliejohnson aberrationindnamethylationinbcelllymphomashasacomplexoriginandincreaseswithdiseaseseverity AT josempolo aberrationindnamethylationinbcelllymphomashasacomplexoriginandincreaseswithdiseaseseverity AT leandrocerchietti aberrationindnamethylationinbcelllymphomashasacomplexoriginandincreaseswithdiseaseseverity AT randydgascoyne aberrationindnamethylationinbcelllymphomashasacomplexoriginandincreaseswithdiseaseseverity AT arimelnick aberrationindnamethylationinbcelllymphomashasacomplexoriginandincreaseswithdiseaseseverity AT franziskamichor aberrationindnamethylationinbcelllymphomashasacomplexoriginandincreaseswithdiseaseseverity |